This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
MyBioSource
product type :
ELISA/assay
product name :
Monkey PON1 (Paraoxonase 1) ELISA Kit
catalog :
MBS2508850
quantity :
24-Strip-Wells
price :
235 USD
product information
catalog number :
MBS2508850
products type :
ELISA Kit
products full name :
Monkey PON1 (Paraoxonase 1) ELISA Kit
products short name :
[PON1]
other names :
[paraoxonase; Serum paraoxonase/arylesterase 1; serum paraoxonase/arylesterase 1; A-esterase 1; K-45; PON 1; aromatic esterase 1; arylesterase B-type; esterase A; paraoxonase B-type; serum aryldiakylphosphatase; serum aryldialkylphosphatase 1; paraoxonase 1; Aromatic esterase 1; A-esterase 1; K-45; Serum aryldialkylphosphatase 1]
products gene name :
[PON1]
other gene names :
[PON1; PON1; ESA; PON; MVCD5; PON; PON 1; A-esterase 1]
uniprot entry name :
PON1_HUMAN
reactivity :
Monkey
sequence length :
355
specificity :
This kit recognizes Monkey PIIINP in samples. No Significant cross-reactivity or interference between MonkeyPIIINP and analogues was observed.
storage stability :
Store at 4 degree C.
other info1 :
Samples: Serum, Plasma And Other Biological Fluids. Assay Type: Quantitative Sandwich. Detection Range: 23.44-1500 pg/mL. Sensitivity: 14.06pg/mL.
other info2 :
Intra-assay Precision: Intra-assay Precision (Precision within an assay): 3 samples with low, midrange and high level MonkeyPIIINP were tested 20times on one plate, respectively. Inter-assay Precision: Inter-assay Precision (Precision between assays): 3 samples with low, midrange and high level MonkeyPIIINP were tested on 3 different plates, 20replicates in each plate.
products description :
Intended Uses: This ELISA kit applies to the in vitro quantitative determination of Monkey PIIINP concentrations in serum, plasma and other biological fluids. Principle of the Assay: This ELISA kit uses Sandwich-ELISA as the method. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to PIIINP. Standards or samples are added to the appropriate micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for PIIINP and Avidin-Horseradish Peroxidase (HRP) conjugate is added to each micro plate well successively and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain PIIINP, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm +/-2 nm. The OD value is proportional to the concentration of PIIINP. You can calculate the concentration of PIIINP in the samples by comparing the OD of the samples to the standard curve.
ncbi gi num :
1575043
ncbi acc num :
AAB41835.1
uniprot acc num :
P27169
ncbi mol weight :
39,731 Da
ncbi pathways :
Metabolic Pathways (132956); Phase I, Non P450 Pathway (198854)
ncbi summary :
The enzyme encoded by this gene is an arylesterase that mainly hydrolyzes paroxon to produce p-nitrophenol. Paroxon is an organophosphorus anticholinesterase compound that is produced in vivo by oxidation of the insecticide parathion. Polymorphisms in this gene are a risk factor in coronary artery disease. The gene is found in a cluster of three related paraoxonase genes at 7q21.3. [provided by RefSeq, Oct 2008]
uniprot summary :
PON1: Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. Capable of hydrolyzing a broad spectrum of organophosphate substrates and lactones, and a number of aromatic carboxylic acid esters. Mediates an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation. Genetic variation in PON1 is associated with susceptibility to microvascular complications of diabetes type 5 (MVCD5). These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new- onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. Homozygosity for the Leu-54 allele is strongly associated with the development of retinal disease in diabetic patients. Belongs to the paraoxonase family. Protein type: Secreted, signal peptide; EC 3.1.1.2; Hydrolase; EC 3.1.8.1; Motility/polarity/chemotaxis; Secreted; EC 3.1.1.81; Phosphatase (non-protein); Lipid-binding. Chromosomal Location of Human Ortholog: 7q21.3. Cellular Component: extracellular space; intracellular membrane-bound organelle; extracellular region. Molecular Function: protein homodimerization activity; arylesterase activity; phospholipid binding; calcium ion binding; aryldialkylphosphatase activity. Biological Process: response to external stimulus; response to nutrient levels; dephosphorylation; organophosphate catabolic process; response to toxin; positive regulation of transporter activity; carboxylic acid catabolic process; positive regulation of binding; aromatic compound catabolic process; phosphatidylcholine metabolic process. Disease: Microvascular Complications Of Diabetes, Susceptibility To, 5
size1 :
24-Strip-Wells
price1 :
235 USD
size2 :
48-Strip-Wells
price2 :
450
size3 :
96-Strip-Wells
price3 :
535
size4 :
5x96-Strip-Wells
price4 :
2255
size5 :
10x96-Strip-Wells
price5 :
3975
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!